Cefotaxime
Cefotaxime is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia
- Genitourinary infections
- Gynecologic infection (including pelvic inflammatory disease, endometritis, and pelvic cellulitis)
- Bacteremia and septicemia
- Skin and skin-structure infections
- Intra-abdominal infections including peritonitis
- Bone and joint infections
- Central nervous system infections including meningitis and ventriculitis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Brain abscess (in combination with metronidazole)
- Empyema (in combination with metronidazole)
- Lyme disease: late Lyme arthritis and neuroborreliosis
- STD (Neisseria gonorrhoeae)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia
- Genitourinary infections
- Gynecologic infection (including pelvic inflammatory disease, endometritis, and pelvic cellulitis)
- Bacteremia and septicemia
- Skin and skin-structure infections
- Intra-abdominal infections including peritonitis
- Bone and joint infections
- Central nervous system infections including meningitis and ventriculitis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Brain abscess (in combination with metronidazole)
- Empyema (in combination with metronidazole)
- Lyme disease: late Lyme arthritis and neuroborreliosis
- STD (Neisseria gonorrhoeae)
There's more to see -- the rest of this entry is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved